Radiotherapy Induced Oral Mucositis Treatment Market – By Treatment Type (Medication [Topical, Systemic], Palliative Device (Type [Low-Level Laser Therapy, Oral Cryotherapy], End-user), Severity Type (Mild, Severe) – Global Forecast (2024 – 2032)

Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Rising cancer cases globally 3.2.1.2 Growing government initiatives and funding 3.2.1.3 Increasing public awareness related to cancer therapy 3.2.1.4 Growing technology advancement in radiotherapy 3.2.2 Industry pitfalls & challenges 3.2.2.1 Side effects of treatments 3.2.2.2 High treatment costs 3.3 Growth potential analysis 3.4 Pipeline analysis 3.5 Regulatory landscape 3.6 Porter's analysis 3.7 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company market share analysis 4.3 Competitive analysis of major market players 4.4 Competitive positioning matrix 4.5 Strategy outlook matrix Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Medication 5.2.1 Drugs 5.2.1.1 Topical treatments 5.2.1.1.1 Antibiotics 5.2.1.1.2 Antifungal 5.2.1.1.3 Anti-inflammatory 5.2.1.1.4 Anti-neoplastic 5.2.1.2 Systemic treatments 5.2.2 Distribution channel 5.2.2.1 Hospital pharmacies 5.2.2.2 Retail pharmacies 5.2.2.3 Online pharmacies 5.3 Palliative device 5.3.1 Type 5.3.1.1 Low-level laser therapy (LLLT) devices 5.3.1.2 Oral cryotherapy systems 5.3.1.3 Other palliative devices 5.3.2 End-user 5.3.2.1 Hopsitals 5.3.2.2 Specialty clinics 5.3.2.3 Cancer treatment centers 5.3.2.4 Other end-users Chapter 6 Market Estimates and Forecast, By Severity Type, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Mild oral mucositis 6.3 Moderate oral mucositis 6.4 Severe oral mucositis (SOM) Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 North America 7.2.1 U.S. 7.2.2 Canada 7.3 Europe 7.3.1 Germany 7.3.2 UK 7.3.3 France 7.3.4 Spain 7.3.5 Italy 7.3.6 Netherlands 7.3.7 Rest of Europe 7.4 Asia Pacific 7.4.1 Japan 7.4.2 China 7.4.3 India 7.4.4 Australia 7.4.5 South Korea 7.4.6 Rest of Asia Pacific 7.5 Latin America 7.5.1 Brazil 7.5.2 Mexico 7.5.3 Rest of Latin America 7.6 Middle East and Africa 7.6.1 Saudi Arabia 7.6.2 South Africa 7.6.3 UAE 7.6.4 Rest of Middle East and Africa Chapter 8 Company Profiles 8.1 Amgen Inc. 8.2 Aurora BioScience 8.3 Colgate-Palmolive Company 8.4 Galera Therapeutics 8.5 Enzychem Lifesciences Corporation 8.6 EpicentRx 8.7 Izun Pharmaceuticals 8.8 MuReva Phototherapy Inc. 8.9 Solasia Pharma K.K. 8.10 Soligenix Inc.